Navigation Links
American Chemical Society's Weekly Presspac -- Aug. 29, 2007
Date:9/3/2007

9 A.M., EASTERN TIME, Sept. 3, 2007

Memory enhancement drugs show promise but face growing scrutiny
Chemical & Engineering News

In our aging society, with an increased urgency to develop new compounds that target serious illnesses like Alzheimers and Parkinsons disease, memory enhancement drugs are becoming a big business. But these same drugs are also creating a growing ethical controversy over their potential off-label uses, such as taking these drugs as performance enhancers to gain a competitive advantage in the workplace. These issues, along with the biochemistry of memory, are explored in an article (http://pubs.acs.org/cen/coverstory/85/8536cover.html)scheduled for the Sept. 3 issue of Chemical & Engineering News (C&EN), ACS weekly newsmagazine.

Right now, there are only a handful of memory-enhancing drugs on the market. In the C&EN cover story, senior editor Sophie L. Rovner describes work at several companies, from small start-ups to pharmaceutical giants, that are developing and testing a variety of memory enhancing products that show promise for the treatment of Alzheimers, Parkinsons, stroke and schizophrenia. In the continuing search for better drugs, even familiar compounds such as nicotine and coffee are being explored for their potential memory-enhancing effects, Rovner notes.

Despite their promise, theres growing regulatory and ethical concern about the use of such drugs for non-medical purposes. This includes using memory-enhancing compounds as stimulants to gain a competitive edge in the workplace or even on exams, which could result in unfair advantages over people who do not use the drugs. The possibility of off-label or recreational uses of these drugs could ultimately limit their wider acceptance, the article suggests. For better or for worse, memory-enhancing drugs are poised to play a bigger role in the future.

ARTICLE
'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., A major discovery is challenging accepted thinki...sociated with diseases such as Alzheimer,s and Par... therapeutics. , It was believed that amyloid fi...ometimes known as fibres - are inert, but that the...h can damage cells and cause disease. , But in ...
(Date:12/3/2009)..., Our ability to learn new information and adapt t...retain lifelong memories, appears to lie in the mi...rding to a new study by NYU Langone Medicine Cente...week in the journal Nature . , The scientists,...physiology and neuroscience at NYU School of Medic...
(Date:12/3/2009)...Contents of this message: , , Preliminary Pre...p to California Academy of Sciences museum, Atte..., NCSWA holiday dinner registration deadline 10..., News Media Registration Form pre-registration d... , For important information regarding visas fo...
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 1Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 2Foreign Physician Growth in the U S and the Impact on Medical Credentialing 55645 3Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 1Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 2Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
...prehensive national study of how carbon dioxide em...isheries, marine mammals, coral reefs, and other n... the National Science Foundation. , "Carbon diox...ng of fossil fuels is not only contributing to atm...ski, director of scientific programs and chief sci...
... Ariz. Oct. 21, 2008 TGen has spun off its third...ical information source for oncologists. , The fo...a variety of data sources, including genetic-based...sed Translational Genomics Research Institute. , ...ncologists with the knowledge they need to design ...
... New South Wales (UNSW) research has highlighted a...t before and during pregnancy. The work in animals... likely to have babies with more body fat, who are...isorders later in life. , Previous research shows...nt are overweight. , The research, published in t...
Other Biology News:NOAA and NSF commission national study of ocean acidification 2TGen spin-off MedTrust Online enables cancer doctors to quickly obtain best-available information 2Overweight mums have chubby bubs 2
(Date:12/3/2009)...HOPKINTON, Mass., Dec. 3 ...eading provider of tools and services for drug dis...d Living Image 4.0 software for IVIS® in vivo... more than 800 Caliper IVIS systems currently inst...features advanced spectral unmixing tools to enhan...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker...s available in its catalogue: ,, Carbondioxide...http://www.reportlinker.com/p0164368/Carbondioxide..., Incubators are the most critical equipment us...d other applications for providing a controlled en...
(Date:12/2/2009)..., CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Onco...) (TSX:ONC; NASDAQ: ONCY ) announced today that in...ering, the underwriters have exercised in full the...al 637,500 units. Each unit is comprised of one co...ant, and was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Lt...oral JAK2 inhibitor, SB1518, at The American Socie...n in New Orleans. ,, Data will be presented on ...ion trial of SB1518 detailing its safety, tolerabi...rofile in dose levels ranging from 100 to 600 mg. ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...May Minimize Viral Transmission, Including Norovir...zer may significantly impact public health by mini...ding norovirus, from food handlers and care provid...a, Ontario, Canada, and North Carolina State Unive... 2008 issue of the journal Applied and Environmen...
...iversity researcher has created a compound that pr...nd could lead to a treatment for the disease. , "...aths and thousands of illnesses, and there is curr...rofessor that led the molecular design team. "Alth...ncern that SARS could return or be used as a biolo...
...Sensors & Controls™ (Gems), a global lea...iniature solenoid valves, and fluidic systems has ...nsors. The UCL-520 Series is suitable for non-cont...t, wastewater management, chemical storage as well... Plainville, CT (Vocus) Dec...
Other Biology Technology:Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3GEMS Introduces Ultrasonic Continuous Liquid Level Sensor for Challenging Fluid Measurement 2
... clone 8G8/5 GenBank Accession Number : NM_002542...ma fusion protein corresponding to residues 166-22...an AP-2γ Formulation: 0.1M Tris-glycine, pH ...ition of glycerol to 30% Quality Assurance: routin...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Mouse Anti-Mucin 3 (MUC3) Ab-2 Monoclonal Antibody, Unconjugated, Clone 1143/B7 from Lab Vision
...the caudal-related homeobox family, is an intestin...h proliferation and differentiation in intestinal ...iggering cells towards the phenotype of differenti...nce of the phenotype. Clone CDX2-88 reacts with a ...
Biology Products: